WCM Investment Management
RARE icon

WCM Investment Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

WCM Investment Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-163,272
Closed -$3.72M – 281
2025
Q4 		$3.72M Sell
163,272
-124,837
-43% -$4.11M 0.01% 188
2025
Q3 		$8.75M Buy
288,109
+77,640
+37% +$2.33M 0.02% 148
2025
Q2 		$7.69M Buy
210,469
+8,256
+4% +$298K 0.02% 151
2025
Q1 		$7.65M Buy
202,213
+66,604
+49% +$2.77M 0.02% 154
2024
Q4 		$5.73M Sell
135,609
-9,740
-7% -$483K 0.01% 174
2024
Q3 		$7.91M Sell
145,349
-9,326
-6% -$475K 0.02% 156
2024
Q2 		$6.41M Buy
154,675
+2,175
+1% +$92.9K 0.02% 155
2024
Q1 		$7.12M Buy
152,500
+31,515
+26% +$1.49M 0.02% 150
2023
Q4 		$5.84M Buy
120,985
+13,220
+12% +$512K 0.02% 160
2023
Q3 		$3.85M Buy
107,765
+2,460
+2% +$97.5K 0.01% 161
2023
Q2 		$4.87M Buy
105,305
+7,488
+8% +$347K 0.01% 158
2023
Q1 		$3.92M Buy
97,817
+1,047
+1% +$44.9K 0.01% 165
2022
Q4 		$4.48M Buy
96,770
+6,715
+7% +$264K 0.02% 163
2022
Q3 		$3.65M Buy
90,055
+6,612
+8% +$340K 0.01% 152
2022
Q2 		$5.03M Sell
83,443
-164
-0.2% -$10.1K 0.02% 148
2022
Q1 		$6.07M Buy
83,607
+6,898
+9% +$480K 0.02% 140
2021
Q4 		$6.45M Buy
76,709
+3,297
+4% +$268K 0.01% 147
2021
Q3 		$6.62M Buy
73,412
+506
+0.7% +$45.7K 0.02% 142
2021
Q2 		$6.95M Buy
72,906
+2,841
+4% +$296K 0.02% 136
2021
Q1 		$7.98M Sell
70,065
-1,664
-2% -$227K 0.02% 122
2020
Q4 		$9.93M Buy
71,729
+3,917
+6% +$465K 0.03% 113
2020
Q3 		$5.57M Buy
67,812
+4,166
+7% +$345K 0.02% 129
2020
Q2 		$4.98M Buy
63,646
+2,075
+3% +$137K 0.02% 130
2020
Q1 		$2.74M Buy
+61,571
New +$3.2M 0.02% 140

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

WCM Investment Management's RARE Position: Q1 2026 in Review

WCM Investment Management sold out of Ultragenyx Pharmaceutical (RARE) in Q1 2026, closing a stake of 163,272 shares — an estimated $3.72M sold.

WCM Investment Management first reported a position in RARE in Q1 2020 and held it in 24 quarters. The position peaked at $9.93M in Q4 2020. 296 funds tracked by Wall St. Rank hold RARE as of Q1 2026.

  • WCM Investment Management reported no remaining Ultragenyx Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • WCM Investment Management sold 163,272 Ultragenyx Pharmaceutical shares in Q1 2026, an estimated $3.72M.
  • WCM Investment Management first reported a position in Ultragenyx Pharmaceutical in Q1 2020 and held it in 24 quarters.
  • WCM Investment Management's Ultragenyx Pharmaceutical position peaked at $9.93M in Q4 2020.
  • 296 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q1 2026.

Based on WCM Investment Management's 13F filing for Q1 2026, filed 7 May 2026.